On hold
- New 2024 regulatory text: meaningful benefits standard, data evaluation detail, the six-element analysis format
One clock is the 2024 final rule, not enforced while Labor, HHS and the Treasury reconsider it. The other is the statute, as amended by the CAA, 2021, which continues [1]. "Parity is paused" collapses the two. It is not.
| Provision | Applies from | Status after May 15, 2025 |
|---|---|---|
| General requirements for group plans and coverage | Plan years on or after Jan 1, 2025 | New portions: not enforced by the Departments |
| Meaningful benefits in every classification where M/S benefits exist | Plan years on or after Jan 1, 2026 | Not enforced by the Departments |
| Prohibition on discriminatory factors and evidentiary standards | Plan years on or after Jan 1, 2026 | Not enforced by the Departments |
| Relevant data evaluation for each NQTL | Plan years on or after Jan 1, 2026 | Not enforced by the Departments |
| Six required elements of the comparative analysis | Staged across 2025 and 2026 | Regulatory detail not enforced; statutory duty remains |
| Individual market coverage | Policy years on or after Jan 1, 2026 | HHS asks states to take a similar approach |
Every NQTL comparative analysis needs six elements [2].
The Departments will not enforce the 2024 final rule for a failure before a final ERIC decision plus 18 months. Two limits: only what is new relative to the 2013 rule, and the statutory obligations under the CAA, 2021 continue [1].
Nonenforcement is a promise about federal audits of plans. It is not a change to your contract, your remittance, or the state insurance law your commercial payers answer to.
The 18-month nonenforcement tail runs from that decision. Until there is one, the tail has not started [1].
Reconsidering the 2024 rule, including whether to propose rescinding or modifying it through notice and comment [1].
HHS encouraged states, as primary enforcers for issuers, to adopt a similar approach and will not treat them as failing to enforce if they do. States are not required to follow [1].
Subregulatory guidance, including FAQs Part 45, may be updated during reconsideration [1].
No. The May 15, 2025 statement covers the 2024 final rule only, and only the parts that are new relative to the 2013 rule. It says MHPAEA's statutory obligations, as amended by the CAA, 2021, continue to have effect.
The Departments will not enforce the 2024 rule for failures that occur before a final decision in the ERIC litigation plus an additional 18 months. No final decision had been published when this page was checked, so the 18-month tail has not started.
Yes. The comparative analysis requirement comes from the Consolidated Appropriations Act, 2021, and the statement says statutory obligations continue to apply. What is paused is the 2024 rule's detailed content and data standards for those analyses.
No. HHS encouraged states that enforce MHPAEA against issuers to adopt a similar approach and said it will not treat them as failing to enforce if they do. A state may still enforce the federal statute and its own parity law.
Checked October 25, 2026. Confirm against the source; items marked proposed may change in the final rule.
We reconcile 24 months of 835s against your contracted rates by CPT and month, and show where the parity argument is strong enough to send.